RESI Boston June Recap

By Caitlin Dolegowski, Marketing Manager, LSN

Redefining Early Stage Investments (RESI) Boston June presented by Life Science Nation (LSN) took place in-person at the Westin Copley Plaza on June 5, followed by two-days of virtual partnering on June 6-7. This hybrid event was another RESI success! With over 800 attendees representing over 30 countries across 5 continents, RESI was truly a global event. Almost 50% of participants were active life science investors and the other 50% were made up of mostly early-stage startups, as well as tech hubs and service providers.

The main event at RESI is always partnering, and RESI Boston June hosted 1500+ partnering meetings. Our onsite partnering tables were full during the in-person event and partnering continued virtually for the next two days. The feedback from our attendees is clear, that hybrid is the new way post pandemic, and LSN is committed to offering the hybrid format to expand the partnering opportunities for the RESI community.

Partnering is supplemented at our in-person conference with Investor Panels, the Innovator’s Pitch Challenge and Sponsor Workshops. This conference featured seven investor panels curated in an effort to focus on the dynamic life science ecosystem. Panel topics included the tried-and-true RESI staples, such as Corporate Venture Capital, Big Pharma and Medtech Strategics and in addition presented some focused panels like Women’s Health and Cell & Gene Therapy. LSN is always updating and sourcing active life science investors and the dedication to this work makes for a diverse lineup of seasoned RESI-regular investors as well as new investors.

The Innovator’s Pitch Challenge (IPC) consisted of 56 companies! Pitching companies showcased their technology posters in the exhibit hall and each participating company pitched to a panel of industry experts and active investors by sector. RESI Boston June had 14 sessions in total and Life Science Nation is excited for this increasing turnout in the IPC and the opportunity for the early-stage companies to network and present with relevant investors. Three companies collected the most “RESI cash” a currency exclusive to RESI distributed to attendees to “invest” in the innovation compelling to them. Congratulations to Thrive Bioscience on their first-place finish, Clinials in second and Untech finishing Third.

A thank you to our sponsors for their support of the RESI conference and hosting workshops geared to our RESI community. RESI sponsors highlighted their services and educated attendees during workshops. Our sponsors provided insight into Negotiating Term Sheets, Company Valuation for Fundraising, Maximizing Pre-clinical Development Success for VC-Backed Startups Through CRO Partnerships and IP Considerations for Start-Ups.

LSN had two exciting announcements for the RESI community that made their debut at RESI Boston June. We are happy to announce the debut of a free, daily, newsletter, LifeSci StartUp, will contain the most up-to-date news, information, tools, and more for and about U.S.-based life sciences startups, brought to you in partnership with Big4Bio beginning in July. Additionally, LSN will be launching our newest product, the “Global Partnering Campaign (GPC), Fundraising & Licensing Partner Roadshow Management” a leading-edge platform that integrates LSN’s Investor and Licensing Partner Database and the Salesforce CRM. LSN customized this platform, leveraging years of experience as a broker/dealer helping early-stage life sciences companies attract capital and says it will be a game changer for early-stage startups seeking between $100K and $50M (seed-series B).

The show must go on and LSN is already prepping for RESI Boston September 18-20. RESI will return to Boston in-person on Monday, September 18 at the Boston Park Plaza, followed by two-days of virtual partnering, September 19-20. Register by June 30 to save with super early bird rates.